HuGE Literature Finder
Records
1
-
2
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas. Neuro-oncology 2019 2 21 (8): 981-992. Pemov Alexander, Hansen Nancy F, Sindiri Sivasish, Patidar Rajesh, Higham Christine S, Dombi Eva, Miettinen Markku M, Fetsch Patricia, Brems Hilde, Chandrasekharappa Settara C, Jones Kristine, Zhu Bin, Wei Jun S, , , Mullikin James C, Wallace Margaret R, Khan Javed, Legius Eric, Widemann Brigitte C, Stewart Douglas |
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Jan 26 (1): 13-21. Sorich M J, Wiese M D, Rowland A, Kichenadasse G, McKinnon R A, Karapetis C |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: